Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 8,901–8,925 of 27,380 studies, newest first · page 357 of 1096.

May 2022 8

  1. 2022-05-02

    Flavonoids as Potential Anti-Inflammatory Molecules: A Review

    ✓ Peer-reviewed Inflammation and the immune system Molecules (Basel, Switzerland)

    Key finding: Studies show that flavonoids activate antioxidant pathways that render an anti-inflammatory effect. +4 more findings

  2. 2022-05-02

    Longitudinal Changes in Hearing and Visual Impairments and Risk of Dementia in Older Adults in the United States

    ✓ Peer-reviewed Disparities JAMA network open

    Key finding: Compared with no sensory impairment, DSI was associated with increased risk of all-cause dementia (hazard ratio [HR], 2.60; 95% CI, 1.66-2.06; P Conclusions and relevance In this cohort study, DSI was associated with increased risk of dementia, particularly AD. +4 more findings

  3. 2022-05-02

    Association of Dual Decline in Cognition and Gait Speed With Risk of Dementia in Older Adults

    ✓ Peer-reviewed Disparities JAMA network open

    Key finding: Of 19 114 randomized participants, 16 855 (88.2%) had longitudinal gait and cognitive data for inclusion in this study (mean [SD] age, 75.0 [4.4] years; 9435 women [56.0%], 7558 participants [44.8%] with 12 or more years of education). +4 more findings

  4. 2022-05-02

    Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome

    ✓ Peer-reviewed Disparities JAMA network open

    Key finding: The variability in disease onset was compared with that of autosomal dominant Alzheimer disease. +4 more findings

  5. 2022-05-01
  6. 2022-05-01

    Caregiving Burden Among Caregivers of People With Dementia Through the Lens of Intersectionality

    ✓ Peer-reviewed Disparities The Gerontologist

    Key finding: Surprisingly, compared to White female caregivers, all the other groups were 37% (95% CI 0.41-0.95) to 71% (95% CI 0.15-0.56) less likely to have emotional burden. +1 more finding

  7. 2022-05-01

    Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US

    ✓ Peer-reviewed Brain scans and imaging JAMA neurology

    Key finding: These findings suggest that at current expected prices, neither aducanumab nor donanemab would be cost-effective for early AD in the US. +1 more finding

  8. 2022-05-01

    Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies

    ✓ Peer-reviewed Prevention and risk European journal of preventive cardiology

    Key finding: These results confirm the absence of a neurocognitive risk associated with statin treatment and suggest a potential favourable role of statins. +4 more findings

April 2022 17

  1. 2022-04-30

    Gut Microbiota Modification via Glucagon-like Peptide-1 with Beneficial Neuroprotective Effects

    ✓ Peer-reviewed Drug development Middle East journal of digestive diseases

    Key finding: The results showed that intestinal expression of GLP-1 1 could reduce the intestinal pathogenic genus such as Enterobacteriaceae and was obviously associated with a greater number of beneficial genera such as Lactobacillus and Akkermansia. +3 more findings

  2. 2022-04-29

    Plasma Phosphorylated-tau181 Is a Predictor of Post-stroke Cognitive Impairment: A Longitudinal Study

    ✓ Peer-reviewed Biomarkers Frontiers in Aging Neuroscience

    Key finding: Of 136 patients, 40 and 50 patients developed PSCI at 3 and 12 months after stroke, respectively. +4 more findings

  3. 2022-04-29

    Dyadic Enrollment in a Phase 3 Mild Cognitive Impairment Clinical Trial

    ✓ Peer-reviewed Disparities Alzheimer disease and associated disorders

    Key finding: Among 769 randomized dyads, 73% were spousal, 14% adult child, and 13% other dyads. +1 more finding

  4. 2022-04-29

    Susac syndrome: challenges in the diagnosis and treatment

    ✓ Peer-reviewed Risk factors Brain : a journal of neurology

    Key finding: Third, in many cases, Susac syndrome is diagnosed and treated late, with significant irreversible sequelae including dementia, blindness and hearing loss.

  5. 2022-04-29

    Molecular recognition of the interaction between ApoE and the TREM2 protein

    ✓ Peer-reviewed Genetics Translational neuroscience

    Key finding: The results indicate that the binding energy between ApoE and TREM2 occurs in an isoform-dependent manner with the following potency rank order: ApoE4 > ApoE3 > ApoE2. +1 more finding

  6. 2022-04-29

    Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain

    ✓ Peer-reviewed Brain scans and imaging Microbiome

    Key finding: These findings demonstrate that the aging gut microbiota drives detrimental changes in the gut-brain and gut-retina axes suggesting that microbial modulation may be of therapeutic benefit in preventing inflammation-related tissue decline in later life. +3 more findings

  7. 2022-04-29

    Determinants of technology adoption and continued use among cognitively impaired older adults: a qualitative study

    ✓ Peer-reviewed Health systems and care delivery BMC geriatrics

    Key finding: Future research is encouraged to validate our findings in a postpandemic era and to further develop a novel theoretical framework for technology acceptance among older adults with cognitive impairments.

  8. 2022-04-29

    Comparing the care experiences of Medicare Advantage beneficiaries with and without Alzheimer's disease and related dementias

    ✓ Peer-reviewed Health systems and care delivery Journal of the American Geriatrics Society

    Key finding: Among beneficiaries sampled by CAHPS, 22.2% with ADRD completed the survey compared to 38.5% without ADRD. +4 more findings

  9. 2022-04-28

    Therapeutic news in Alzheimer's disease: Soon a disease-modifying therapy?

    ✓ Peer-reviewed Treatments Revue neurologique

    Key finding: However, in the last three years, four molecules have shown significant effects on clinical endpoints in phase II or III clinical trials (i.e., slowing of cognitive decline). +1 more finding

  10. 2022-04-28

    The brain structure and genetic mechanisms underlying the nonlinear association between sleep duration, cognition and mental health

    ✓ Peer-reviewed Genetics Nature aging

    Key finding: The brain regions most significantly underlying this interconnection included the precentral cortex, the lateral orbitofrontal cortex and the hippocampus. +2 more findings

  11. 2022-04-28

    Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort

    ✓ Peer-reviewed Cognitive tests and assessment EClinicalMedicine

    Key finding: The pattern of deficits across tasks was qualitatively compared with normal age-related decline, and early-stage dementia. +2 more findings

  12. 2022-04-28

    Structural progression of Alzheimer's disease over decades: the MRI staging scheme

    ✓ Peer-reviewed Disease mechanisms Brain communications

    Key finding: We concluded that this MRI scheme of atrophy progression in Alzheimer's disease was close but did not entirely overlap with Braak staging of tauopathy, with a 'reverse chronology' between limbic and entorhinal stages. +1 more finding

  13. 2022-04-28

    Myeloid LXR (Liver X Receptor) Deficiency Induces Inflammatory Gene Expression in Foamy Macrophages and Accelerates Atherosclerosis

    ✓ Peer-reviewed TREM2 and immune genetics Arteriosclerosis, thrombosis, and vascular biology

    Key finding: Cholesterol loaded macrophage foam cells are a prominent feature of atherosclerotic plaques. +3 more findings

  14. 2022-04-27

    Amyloid-β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk-AMPK pathway

    ✓ Peer-reviewed Inflammation and the immune system Aging cell

    Key finding: However, the precise molecular mechanism through which the NLRP3 inflammasome is associated with AD pathologies remains unclear. +2 more findings

  15. 2022-04-27

    The genetic architecture of Alzheimer disease risk in the Ohio and Indiana Amish

    ✓ Peer-reviewed Genetics HGG advances

    Key finding: Although APOE ε4 remains the largest genetic risk factor for AD, more than 26 other loci have been associated with AD risk. +2 more findings

  16. 2022-04-27

    Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion

    ✓ Peer-reviewed Biomarkers Journal of neurology, neurosurgery, and psychiatry

    Key finding: In total, samples from 610 individuals from four clinical centres were investigated in this study. +4 more findings

  17. 2022-04-27

    The Effect of Transcranial Alternating Current Stimulation With Cognitive Training on Executive Brain Function in Individuals With Dementia: Protocol for a Crossover Randomized Controlled Trial

    ✓ Peer-reviewed Treatments JMIR research protocols

    Key finding: We anticipate that transcranial alternating current stimulation will be a well-tolerated treatment, with no serious side effects and with considerable short- and long-term cognitive improvements. +1 more finding

Browse the library by subject, with the full score breakdown →